AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Top 32%
#1591 out of 5080 analysts
Average Return
+21.43%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | +81.97% | $17.64 | $32.10 | 2025-07-22 - 2025-10-28 | Buy |
Structure Therapeutics IncGPCR | +78.70% | $16.20 | $28.95 | 2025-08-06 - 2025-10-28 | Buy |
Avidity Biosciences IncRNA | +56.46% | $44.74 | $70.00 | 2025-09-11 - 2025-10-27 | Buy |
Annexon IncANNX | +41.39% | $2.44 | $3.45 | 2025-08-14 - 2025-10-28 | Buy |
Maze Therapeutics IncMAZE | +37.80% | $23.30 | $32.10 | 2025-09-11 - 2025-10-28 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pepgen IncPEPG | 2 | Buy | $18.00 | +261.45% | Maintains | 3 days ago |
Avidity Biosciences IncRNA | 2 | Hold | $72.00 | +2.96% | Downgrades | 3 days ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +355.41% | Maintains | 21 days ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +1,182.05% | Initiates Coverage On | a month ago |
Maze Therapeutics IncMAZE | 3 | Buy | $50.00 | +55.76% | Reiterates | a month ago |
Annexon IncANNX | 1 | Buy | $14.00 | +305.80% | Reiterates | 2 months ago |
Structure Therapeutics IncGPCR | 1 | Buy | $60.00 | +107.25% | Maintains | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.